You just read:

Two Day Seminar: Effectively Addressing and Remediating FDA's Form 483 Findings, Warning Letters and Consent Decree Compliance Issues (Orlando, FL, United States - June 19-20, 2017) - Research and Markets

News provided by

Research and Markets

Mar 06, 2017, 05:00 ET